MAPT and Atrophy: The strongest association between MAPT expression and the atrophy pattern in symptomatic MAPT mutation carriers was measured with microarray probe A_24_P224488, which showed a non-significant positive association z = 0.867 (PFDR=0.15; Fig. 2).